Your browser doesn't support javascript.
loading
Very long-term molecular follow-up of minimal residual disease in patients with neuroblastoma.
Tchirkov, Andrei; Greze, Victoria; Plantaz, Dominique; Rouel, Nadège; Vago, Philippe; Kanold, Justyna.
Afiliação
  • Tchirkov A; CHU de Clermont-Ferrand, Service de Cytogénétique Médicale, Hôpital Estaing, Clermont-Ferrand, France.
  • Greze V; U1240 Imagerie Moléculaire et Stratégies Théranostiques, INSERM, Université Clermont Auvergne, Clermont Ferrand, France.
  • Plantaz D; Faculté de Médecine, Université Clermont Auvergne, Clermont-Ferrand, France.
  • Rouel N; Faculté de Médecine, Université Clermont Auvergne, Clermont-Ferrand, France.
  • Vago P; CHU de Clermont-Ferrand, Service d'hématologie et d'oncologie pédiatrique, Hôpital Estaing, Clermont-Ferrand, France.
  • Kanold J; Unité CRECHE, INSERM-CIC 1405, Clermont-Ferrand, France.
Pediatr Blood Cancer ; 65(12): e27404, 2018 12.
Article em En | MEDLINE | ID: mdl-30216652

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasia Residual / Neuroblastoma Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2018

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasia Residual / Neuroblastoma Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2018